ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #5,584Gold OA

Infectious Agents and Cancer

Acronym:iaac
•
Abbreviation (ISO):INFECT AGENTS CANCER
•
Identifier (ISSN):1750-9378(Print)
•
Publisher:BioMed Central
Clarivate IF (2026)
3.2↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Infectious Agents and Cancer

WoS Q3
12452.1220182.4720192.7420202.9620213.720223.720233.120242.820253.22026
Annual Impact Factor Metric
Current (2026):3.2
Scopus SJR & RankScopus Q2
0.92
#5,584

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
54

54 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate3.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
66articles/year
100% Gold OA•74.58% Original Research

Aims & Scope

Infectious Agents and Cancer is an open access, peer-reviewed online journal that encompasses all aspects of basic, clinical, epidemiological and translational research providing an insight into the association between chronic infections and cancer. The journal welcomes submissions in the pathogen-related cancer areas and other related topics, in particular: • HPV and anogenital cancers, as well as head and neck cancers; • EBV and Burkitt lymphoma; • HCV/HBV and hepatocellular carcinoma as well as lymphoproliferative diseases; • HHV8 and Kaposi sarcoma; • HTLV and leukemia; • Cancers in Low- and Middle-income countries. The link between infection and cancer has become well established over the past 50 years, and infection-associated cancer contribute up to 16% of cancers in developed countries and 33% in less developed countries. Preventive vaccines have been developed for only two cancer-causing viruses, highlighting both the opportunity to prevent infection-associated cancers by vaccination and the gaps that remain before vaccines can be developed for other cancer-causing agents. These gaps are due to incomplete understanding of the basic biology, natural history, epidemiology of many of the pathogens that cause cancer, the mechanisms they exploit to cause cancer, and how to interrupt progression to cancer in human populations. Early diagnosis or identification of lesions at high risk of progression represent the current most critical research area of the field supported by recent advances in genomics and proteomics technologies.

Topics Covered (Recognized by AI)
MedicineBiologyGeneticsInternal MedicinePathologyImmunologyOncology & Cancer ResearchVirologyChemistryBiochemistryFamily MedicineMathematicsSurgeryOncologySociologyCancer ResearchDemography
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q3
Rank103/183
IndexSCIE
JCRSCIE2026

ONCOLOGY

Q2
Rank161/333
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q3
Rank114/183
IndexSCIE
JCISCIE2026

ONCOLOGY

Q3
Rank185/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.2
Articles / Year64
Total Citations18
2025
IF2.8
Articles / Year96
Total Citations285
2024
IF3.1
Articles / Year65
Total Citations349
2023
IF3.7
Articles / Year84
Total Citations836
2022
IF3.698
Articles / Year64
Total Citations963

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,584Scopus Q2SCImago Profile
Scopus Coverage:2006-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q2
0.92

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.17

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,113 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations721
3-Year Documents203
Citable Documents195

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate50.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

EpidemiologyQ2
Infectious DiseasesQ2
OncologyQ2
Cancer ResearchQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Infectious Agents and Cancer (acronym: iaac, abbr: INFECT AGENTS CANCER, ISSN: 1750-9378) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by BioMed Central in England since 2006. The periodical holds a Journal Impact Factor (JIF) of 3.20, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.920 (Q2), an H-index of 54.

The journal enforces rigorous peer evaluation with an annual output of approximately 66 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,113 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
BioMed Central
Publication Language
English
Frequency
Periodic
Founding Year
2006
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 379ace18-df63-4569-8ac4-386cd80c19e6
Database Updated: 2026-09-28